CLDN18 and cancer: We tested the prognostic impact of CLDN18 on the series of 45 stage IV cases, in which 10 (22.2%) tumours showed high CLDN18 expression, but the association between CLDN18 status and patients’ prognosis was not significant in this small series of advanced cancers.